In Zhytomyr region the state will reimburse the cost of drugs to patients with diabetes mellitus type 2
One of today's priorities in the sphere of health protection of Ukraine is the treatment of patients with diabetes type 2 diabetes. Among the immediate steps the government envisages: the establishment of a clear mechanism of issuing prescriptions using international non-proprietary names (INN), establishing the system of payment to pharmacies, the implementation of the electronic registry of patients and the like. November 9, 2016 the Cabinet of Ministers of Ukraine adopted a resolution ¹ 863 "On the introduction of reimbursement of medicines". This regulation applies to medicinal products in the prescribed manner, registered in Ukraine, entered in the national list of essential medicines, approved by the decree of the Cabinet of Ministers of Ukraine dated 25 March 2009 No. 333 “on Some issues of state regulation of prices for medicines and products of medical appointment” (the Official Bulletin of Ukraine, 2009, ¹ 27, article 906; 2016, No. 3, article 166), which cost shall be compensated during outpatient treatment of persons suffering from, in particular, diabetes mellitus type 2, namely, only two hypoglycemic agents (INN): Metformin (Metformin) and Gliclazide (Gliclazide). Prescriptions for the above drugs will be prescribed only by family doctors at the place of rendering of medical aid to patients suffering from diabetes type 2, on prescription blanks of form ¹ 1 indicating the international nonproprietary name of the medicine, dosage and method of production. Reimbursement of cost of medicines will be carried out at the expense of targeted subventions from the state budget to local budgets. This was reported in the Zhytomyr regional state administrationÏåðåâåäåíî ñåðâèñîì "ßíäåêñ.Ïåðåâîä÷èê": translate.yandex.ru.
Source: http://uzinform.com.ua/
